✦ LIBER ✦

The regulatory landscape for actively personalized cancer immunotherapies

✍ Scribed by Britten, Cedrik M; Singh-Jasuja, Harpreet; Flamion, Bruno; Hoos, Axel; Huber, Christoph; Kallen, Karl-Josef; Khleif, Samir N; Kreiter, Sebastian; Nielsen, Michaela; Rammensee, Hans-Georg; Sahin, Ugur; Hinz, Thomas; Kalinke, Ulrich

Book ID: 121308413
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 443 KB
Volume: 31
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt.2708

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ACTIVE IMMUNOTHERAPY FOR CANCER

✍ Schinitsky, MichaelR. 📂 Article 📅 1973 🏛 The Lancet 🌐 English ⚖ 298 KB

Regulatory T cells—an important target f

Regulatory T cells—an important target for cancer immunotherapy

✍ Shin, Jae Il; Ha, Sang-Jun 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 546 KB

ACTIVE SPECIFIC IMMUNOTHERAPY FOR OVARIA

ACTIVE SPECIFIC IMMUNOTHERAPY FOR OVARIAN CANCER

✍ Hudson, C.N.; Mchardy, J.E.; Curling, O.M.; English, P.E.; Levin, L.; Poulton, T 📂 Article 📅 1976 🏛 The Lancet 🌐 English ⚖ 352 KB

Cancer immunotherapy products: Regulator

Cancer immunotherapy products: Regulatory aspects in the European Union

✍ Camarero, Jorge; Ruiz, Sol 📂 Article 📅 2012 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 462 KB

Immunotherapy: Cancer immunotherapy for

Immunotherapy: Cancer immunotherapy for the elderly

✍ Papatriantafyllou, Maria 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

Tim-3: An Emerging Target in the Cancer

Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape

✍ Anderson, A. C. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 451 KB